Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NewAmsterdam Pharma
Biotech
NewAmsterdam drug cuts cholesterol, but by less than expected
NewAmsterdam’s drug reduced cholesterol by 41% at Week 52, confirming the therapy’s efficacy but falling outside of the mark hit in phase 2.
Annalee Armstrong
Jul 29, 2024 8:00am
NewAmsterdam shares more data on lipid-lowering Amgen castoff
Apr 9, 2024 5:30am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
3 Flagship biotechs make key exec hires—Chutes & Ladders
Aug 18, 2023 9:30am
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2
Jan 17, 2023 9:15am
